" Colon Cancer Pipeline Industry 2014 " is the latest addition to Market Research Reports.biz industry research reports collection. To order report Call +1-518-618-1030 or send an email on sales@marketresearchreports.biz with Colon Cancer Pipeline Industry in subject line.
Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Colon Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colon Cancer and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigation drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic inundation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
- The report provides a snapshot of the global therapeutic landscape of Colon Cancer
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Colon Cancer and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Colon Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of mono therapy and combination therapy pipeline projects
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Colon Cancer
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Introduction
Colon Cancer Overview
Therapeutics Development
Colon Cancer - Therapeutics under Development by Companies
Colon Cancer - Therapeutics under Investigation by Universities/Institutes
Colon Cancer - Pipeline Products Glance
Colon Cancer - Products under Development by Companies
Colon Cancer - Products under Investigation by Universities/Institutes
Colon Cancer - Companies Involved in Therapeutics Development
Drug Profiles
Colon Cancer - Recent Pipeline Updates
Colon Cancer - Dormant Projects
Colon Cancer - Discontinued Products
Colon Cancer - Product Development Milestones
Appendix
Number of Products under Development for Colon Cancer, H1 2014
Number of Products under Development for Colon Cancer - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Development by Companies, H1 2014 (Contd..1)
Number of Products under Development by Companies, H1 2014 (Contd..2)
Number of Products under Development by Companies, H1 2014 (Contd..3)
Number of Products under Development by Companies, H1 2014 (Contd..4)
Number of Products under Development by Companies, H1 2014 (Contd..5)
Number of Products under Development by Companies, H1 2014 (Contd..6)
Number of Products under Development by Companies, H1 2014 (Contd..7)
Colon Cancer - Pipeline by Cold Genesys, Inc., H1 2014
Colon Cancer - Pipeline by Cancer Prevention Pharmaceuticals, Inc., H1 2014
Colon Cancer - Pipeline by Zensun (Shanghai) Sci & Tech Co., Ltd., H1 2014
Colon Cancer - Pipeline by PsiOxus Therapeutics, Ltd., H1 2014
Colon Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2014
Colon Cancer - Pipeline by CureFAKtor Pharmaceuticals. LLC, H1 2014
Colon Cancer - Pipeline by Kancera AB, H1 2014
Colon Cancer - Pipeline by Jasco Pharmaceuticals, LLC., H1 2014
About Us
Market Research Reports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact Us
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: +1-866-997-4948
0 comments:
Post a Comment